Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

MOD > Chapter 7 Part 3 > Flashcards

Chapter 7 Part 3 Flashcards

1
Q

What is the stepwise acquisition of mutations that lead to the development of cancer?

A
  1. Initial carcinogen induced mutation
  2. mutation affecting genomic integrity
  3. additional driver mutations, acquisition of cancer hallmarks
  4. Additional mutations and emergence of subclones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Eight fundamental changes in cell physiology considered hallmarks of CA

A
  1. self-sufficiency in growth signals
  2. Insensitivity to growth-inhibitory signals
  3. altered cell metabolism
  4. Evasion of apoptosis
  5. Limitless replicative potential
  6. sustained angiogenesis
  7. ability to invade and metastasize
  8. ability to evade host immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a proto-oncogene?

A

growth promoter, involved in normal cell division and growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an oncogene?

A

cancer-causing gene, promote autonomous growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What allelic mutations are needed to promote neoplasia?

A

Conversion of one of two alleles from proto-oncogene to an oncogene, or loss of both tumor suppressor alleles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an oncoprotein?

A

resembles normal product of proto-oncogenes but contains mutations that inactivate internal regulatory elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mode of action of growth factor oncogene

A

Growth factors can acquire the ability to synthesize their own growth factors and cause autocrine stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mode of action of growth factor receptor oncogene

A

constiutive, growth-factor independent tyrosine kinase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EGFR1 gene product and associated CA

A

epidermal growth factor receptor, lung adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

EGFR2 gene product and associated CA

A

HER2 tyrosine kinase, amplified in breast carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALK proto-oncogene activation and associated CA

A

translocation or fusion with EML4, associated with lymphomas and adenocarcinomas of the lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Function of RAS proteins

A

signal transduction from RTKs to MAPK/PI3K pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common point mutation result of RAS proteins

A

decreased GTPase activity resulting in constitutive pro-growth signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancers associated with RAS protein mutations

A

colon, lung, pancreatic, bladder, kidney, melanomas, hematologic, pituitary, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Result of activating BRAF mutation

A

downstream kinase and transcription factor activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mode of activation of BRAF and associated CAs

A

point mutation, melanomas, leukemias, colon carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ABL tyrosine kinase mode of activation and associated CA

A

translocation of gene from C9 to C22 - BCR-ALK gene product, acute lymphoblastic leukemias and chronic myelogenous leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Main actions of MYC

A

activates genes involved in cell growth – protein synthesis, cell cycle progression; upregulates telomerase, reprogram somatic cells to stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MYC mechanism of activation in tumor and associated CA

A

translocation, Burkitt lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CA associated with constiutive Wnt signaling

A

colon carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CA associated with constiutive HH signaling

A

meduloblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mechanism of activation in tumor of cyclin and associated CA

A

Translocation - mantle cell lymphoma and multiple myeloma

Amplification - breast and esophageal CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mechanism of activation in tumor of CDKs and associated CA

A

amplification or pt mutation, glioblastoma, melanoma, sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Main function of RB

A

tumor suppressor protein that binds E2F transcription factors in hypophosphorylated state to prevent G1/S transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Main function of p53
tumor suppressor, acts through p21 to cause cell cycle arrest, causes apoptosis
26
Proto-Oncogene mutations result in...
excessive increase in one or more normal functions encoded in gene
27
tumor-suppressor mutations result in...
lack of growth inhibition, requires both alleles to be damages
28
mutations in genes that regulate apoptosis result in...
less death, enhanced survival
29
mutations in DNA-repair genes result in...
impaired ability to recognize and repair nonlethal genetic damage, can result in genetic instability
30
APC function
inhibit WNT signaling
31
APC familial syndromes and CAs
familial colonic polyps and carcinomas, carcinomas of stomach, colon, pancreas; melanoma
32
NF1 function
inhibit RAS/MAPK signaling
33
NF2 function
cytoskeletal stability
34
NF1 familial syndromes and CAs
neurofibromatosis type 1; neuroblastoma, juvenile myeloid lukemia
35
NF2 familial syndromes and CAs
Neurofibromatosis type 2; schwannoma, meningioma
36
PTCH function
inhibitor of HH
37
PTCH familial syndromes and CAs
Gorlin syndrome; basal cell carcinoma, medulloblastoma
38
VHL function
inhibitor of hypoxia induced transcription factors
39
VHL familial syndromes and CAs
Von Hippel Lindau syndrome; renal cell carcinomas
40
CDH1 function
cell adhesion, inhibition of cell motility
41
CDH1 familial syndromes and CAs
familial gastric CA; gastric carcinoma, lobular breast carcinokma
42
BRCA1 / BRCA 2 function
repair ds DNA breaks
43
BRCA1/2 familial syndromes and CAs
familial breast and ovarian carcinoma, carcinomas of male breast, chronic lymphocytic leukemia; sporadic CA development rare
44
MSH function
DNA mismatch repair
45
MSH familial syndromes and CAs
hereditary nonpolyposis colon carcinoma; colonic and endometrial carcinoma
46
WT1 function
transcription factor
47
WT1 familial syndrome and CAs
familial wilms tumor; wilms tumor, certain leukemias
48
What mutations are required to produce retinoblastoma?
two hits involving both RB alleles at 13q14
49
Function of PD-1
checkpoint protein on T cells that prevent T cells from attacking other cells in the body by binding to PD-L1
50
Mabs for PD-1
block binding of PD-1 to PD-L1 to bosst immune response to CA cells
51
CTLA4 function
downregulate immune response, upregulated on T cells after activation
52
Problem with CTLA4 Mab
serious and life-threatening side effects
53
PDE4 function
degrades cAMP in immune cells, prevents anti-inflammatory effects - psoriatic lesion development
54
Epigenome
factors other than DNA sequence that regulate gene expression
55
Methylation of DNA
causes changes in DNA structure and thus causes activation or silencing of genes
56
Histone acetylation
causes changes in chromatin regulatory complexes activating or silencing genes
57
miRNAs
function to modulate translation of mRNAs into their proteins, posttranscriptional silencing of gene expression
58
long noncoding RNA
modulate gene expression by binding to chromatin, restricting RNA polymerase access to coding genes
59
Warburg effect
increased lactose production in the presence of glucose via the glycolytic pathway, demonstrates "glucose hunger" of tumors
60
Is Warburg metabolism cancer specific?
No, it also occurs in growing cells (embryonic)
61
What does Warburg metabolism provide for a cell that oxidative phosphorylation does not?
metabolic intermediates needed for synthesis of cellular components
62
Role of PI3K/AKT in Warburg effect
upregulates glucose transports, glycolytic enzymes, shunts intermediates
63
Role of RTK activity in Warburg effect
upregulate enzymatic activity leading to a build up of glycolytic intermediates
64
Role of MYC activity in Warburg effect
upregulation of glutaminase and glycolytic enzymes
65
How can apoptosis be initiated?
intrinsic or extrinsic pathways
66
Which pathway of apoptosis is more commonly mutated in lesions?
intrinsic
67
What anti-apoptotic gene is most commonly overexpressed in B-cell lymphoma and why?
BCL2 due to a 14;18 translocation
68
How do cancer stem cells arise?
through transformation of a normal stem cell or acquired genetic lesions
69
What two lesions are commonly acquired in cancer cells that convey limitless replicative potential?
inactivated senescence signals and reactivated telomerase
70
Why is angiogenesis important?
required for growth of tumors
71
What triggers angiogenesis?
hypoxia via HIF-1a and VEGF
72
Actions of p53 for angiogenesis
induces synthesis of angiogenesis inhibitor thrombospondin-1
73
Actions of RAS, MYK, MAPK in angiogenesis
upregulate VEGF to stimulate angiogenesis
74
VEGF treatment
inhibitors can be used to prolong the clinical course but are not curative
75
What cells recognize tumor ags?
CD8 T cells
76
Classes of tumor antigens
products of mutated proto-oncogenes, tumor suppressor genes, overexpressed proteins, tumor ags produced by oncogenic viruses, oncofetal antigens, altered glycolipids and glycoproteins and cell-specific differentiation antigens
77
What types of cancer are immunocompromised pts at an increased risk for?
oncogenic DNA viruses
78
how may tumors avoid the immune system?
reduced expression of histocompatabilty antigens, immunosuppression expression, selective outgrowth of antigen-negative variants
79
HNPCC syndrome
hereditary nonpolyposis colon cancer; defects in mismatch repair systems leading to carcinomas of colon
80
xeroderma pigmentosum
defect in nt excision repair, increased risk for skin cancer due to inability to repair pyrimidine dimers
81
Defects in homologous recombination DNA repair system constitute what disorders?
Bloom syndrome, ataxia-telangiectasia, fanconi anemia
82
DNA damage in B and T lymphocyte tumors
occurs due to presence of products that induce genetic instability (RAG1, RAG2, AID)
83
CA enabling effects of inflammatory cells
release of factors that promote proliferation, removal of growth suppressors, enhanced resistance to cell death (anoikis), inducing angiogenesis, activating invasion and metastasis, evading immune destruction
84
oncogenic mutations
point mutations, chromosomal abnormalities, translocations, deletions, amplifications
85
How do balanced translocations contribute to carcinogenesis?
overexpression of oncogenes or fusion protein generation with altered signaling capacity
86
How do deletions contribute to carcinogenesis?
loss of tumor suppressor gene function, activation of proto-oncogenes
87
How do amplifications cause carcinogenesis?
increased expression and function of oncogenes
88
chromothrypsis
shattered chromosome reassembled in haphazard way
89
Translocation of CML
9;22
90
Translocation of AML
8;21 or 15;17
91
Translocation of burkitt lymphoma
8;14
92
Translocation of Mantle cell lymphoma
11;14
93
Translocation of follicular lymphoma
14;18
94
All-trans retinoic acid in acute promyelocytic leukemia
used to activate gene transcription to activate PMNs, PML+RARa translocation normally prevents gene expression with normal RA but ATRA allows for transcription

MOD (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions